PDGFRA antibody (PB9771) performs well in IHC, WB and shows reactivity with Human, Mouse, Rat.

  • Validated for inter-lot consistency, specificity, and reproducibility
  • Committed to quality since 1993
  • Over 4 Publications
Filter:
pb9771 1_1pb9771 2 IHC anti pdgfra pdgf receptor alpha picoband antibodypb9771 ihc 2pb9771 ihc 3pb9771 ihc 4

Anti-PDGF Receptor alpha/PDGFRA Antibody Picoband®

PDGFRA antibody

Reactive SpeciesHostApplication
Human, Mouse, RatRabbitIHC, WB

SKU: PB9771

Size: 100 μg

Bundle to save: I do not want free secondary ab
Price:
$370/100 μg

3 in stock. Ships Next Business Day.

Quantity: 1

1
Get A Quote
Guarantee / Product Promise

Tested Applications

PDGFRA antibody was positively detected by WB in:

human HT1080 whole cell, human Caco-2 whole cell, human U20S whole cell, human PC-3 whole cell, human 293T whole cell

Suggested blocking solution with 5% non-fat milk or BSA; (*)Recommended protein loading: 20-40 ug per lane

PDGFRA antibody was positively detected by IHC in:

Human Intestinal Cancer tissue, human breast cancer tissue, human colon cancer tissue

Use TE buffer pH 9.0 for antigen retrieval; (*) citrate buffer pH 6.0 is an alternative.

Recommend Dilution

Application
Dilution
Species
Immunohistochemistry (Paraffin-embedded Section)
0.5-1μg/ml
Human
Western blot
0.1-0.5μg/ml
Human, Mouse, Rat

* It is recommended to optimize the amount of this reagent in each experimental system to achieve the best results.

Reactive Data

Filter:
Boster Guarantee:What is this?
WB
IHC
IF
Human
Tested
Tested
Recommend
Mouse
Predicted
Predicted
Predicted
Bovine
Predicted
Predicted
Predicted
Sheep
Predicted
Predicted
Predicted
Dog
Predicted
Predicted
Predicted
Monkey
Predicted
Predicted
Predicted
Rat
Predicted
Predicted
Predicted

Product Information

Product Name
Anti-PDGF Receptor alpha/PDGFRA Antibody Picoband®
View all PDGFRA Antibodies
Form
Lyophilized
Uniprot
Gene ID
Storage & Handling
Store at -20˚C for one year from date of receipt. After reconstitution, at 4˚C for one month. It can also be aliquotted and stored frozen at -20˚C for six months. Avoid repeated freeze-thaw cycles.
Host
Rabbit
Contents
Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3.
*This antibody is supplied in a stabilized formulation.
Compatibility with conjugation reactions depends on the chemistry of the conjugation method used.
For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.
Clonality
Polyclonal
Isotype
Rabbit IgG
Immunogen
A synthetic peptide corresponding to a sequence at the C-terminus of human PDGFRA, identical to the related mouse sequence, and different from the related rat sequence by one amino acid.
Cross-Reactivity
No cross-reactivity with other proteins.
Reconstitution
Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Observed Molecular Weight
123 kDa
Calculated Molecular Weight

122.7 kDa

Background of PDGFRA
PDGFRA (Platelet-derived growth factor receptor, alpha), also called PDGFR2, encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. The PDGFA gene is mapped on 4q12. The PDGFRA-FIP1L1 gene is a constitutively activated tyrosine kinase that transforms hematopoietic cells and is a therapeutic target of imatinib. And the PDGFRA gene contains 23 exons spanning about 65 kb. Using the human PDGFRA promoter linked to a luciferase reporter, Joosten et al. showed that PAX1 acts as a transcriptional activator of the PDGFRA gene in differentiated human embryonal carcinoma cells. PDGFRA is responsible for mediating cellular contraction of multiple growth factors: TGFB1 and members of the PDGF family. Lei et al. noted that in the rabbit model of the disease, PDGFRA is dramatically more capable of promoting PVR than is the closely related PDGFRB. PDGFRA is a critical receptor required for human CMV infection, and thus a target for novel antiviral therapies.
Cite This Product
Anti-PDGF Receptor alpha/PDGFRA Antibody Picoband® (Boster Biological Technology, Pleasanton CA, USA, Catalog # PB9771)

Protocols

Western Blot protocol for PDGFRA antibody
Immunohistochemistry (IHC) protocol for PDGFRA antibody

Publications

Application:
Species:
Morphological and immunohistochemical study of perivascular macrophages: Key findings for angiogenesis
Published: 2026-08-06
Journal: DEVELOPMENTAL BIOLOGY
Application: IHC
Impact Factor: 2.10
Species: Quail
PMID: 42562117
Role of Uterine Telocytes During Pregnancy
Published: 2022-12-20
Journal: MICROSCOPY AND MICROANALYSIS
Application: IHC
Impact Factor: 4.10
Species: Rabbit
Janus Kinase 1 Plays a Critical Role in Mammary Cancer Progression
Published: 2018-11-20
Journal: Cell Reports
Application: WB
Impact Factor: 8.03
Species: Human
PMID: 30463015
PDGFRα Regulated by miR-34a and FoxO1 Promotes Adipogenesis in Porcine Intramuscular Preadipocytes through Erk Signaling Pathway
Published: 2017-11-15
Journal: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Application: WB
Impact Factor: 3.23
Species: Pig
PMID: 29140299

Review

Have you used Anti-PDGF Receptor alpha/PDGFRA Antibody Picoband®?

Submit a review and receive $370 in product credits, a $185 Amazon gift card, or our carefully curated gift bundles.

Product Promise

We promise Anti-PDGF Receptor alpha/PDGFRA Antibody Picoband® performs excellently in relevant applications for IHC, WB. If it doesn't perform as promised, we will refund the product. Learn more

In stock
Order Product
PB9771
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
$370.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: Oct 8, 2026